Universität Wien FIND
Achtung! Das Lehrangebot ist noch nicht vollständig und wird bis Semesterbeginn laufend ergänzt.

322056 VO Introduction to Nanomedicine: Nucleic acid therapy and Bioimaging - M14 (2020W)

1.00 ECTS (1.00 SWS), SPL 32 - Pharmazie

An/Abmeldung

Hinweis: Ihr Anmeldezeitpunkt innerhalb der Frist hat keine Auswirkungen auf die Platzvergabe (kein "first come, first served").

Details

Sprache: Englisch

Prüfungstermine

Lehrende

Termine

The lectures will be held in a digital format (on-line) via Moodle by using the 'Collaborate' tool.

All uploaded information/documents (e.g. files, data, etc.) are solely to be used for personal use of the course participant.
Owing to copyright rules and regulations, sharing or uploading of the above to any other platform or social platforms is strictly forbidden.

The schedule for on-line lectures is as follows-
Timeslot: 10:30-12:00
Dates: 9.12.2020, 15.12.2020, 17.12.2020, 12.1.2021, 14.1.2021, 19.1.2021, 20.1.2021, 21.1.2021.

Please email to haider.sami@univie.ac.at for enrolment into Moodle course.


Information

Ziele, Inhalte und Methode der Lehrveranstaltung

This is an introductory course on nanomedicine, with special focus on nucleic acid therapy and bioimaging. Nanomedicine is an upcoming field which is impacting health sciences significantly by developing new nano-pharmaceuticals and investigating the associated challenges.

The course will cover the following topics:-
Introduction to nanotechnology, nanomaterials and nanoscale (within the context of biotechnology and biopharmaceutics)- basic concepts and definitions.

Introduction to nanomedicine (within the general context of biomedical applications and with special focus on nucleic acid therapy and bioimaging)- general concepts, definitions, claims and scope, pharmaceutical and biomedical applications, changing landscape of pharmaceuticals containing nanomaterials, nanomedicine/nanomaterial platforms for nucleic acid therapy and bioimaging applications, selected examples of nanomedicine platforms under pre-clinical trials/clinical trials/clinical use, biological challenges faced by nanomedicines, physicochemical and biological characterization techniques for relevant nanopharmaceutics.

Art der Leistungskontrolle und erlaubte Hilfsmittel

Examination at the end of the course.

Mindestanforderungen und Beurteilungsmaßstab

Attending all the lectures, active participation in the course and performance in the examination.

Prüfungsstoff

Topics covered in the lectures.

Literatur

All required reading materials will be uploaded on the Moodle link of the course.

Zuordnung im Vorlesungsverzeichnis

MA23, A400

Letzte Änderung: Mi 03.02.2021 10:51